Single Source Procurement: New Born Screening Program

Pursuant to New York State Finance Law § 163.10(b), The New York State Department of Health is presenting the following summary of relevant circumstances, and material and substantial reasons why a competitive procurement was not feasible. The Avioq HIV-1 Microelisa assay test system is the only test that is FDA approved for the qualitive detection of HIV antibodies in oral fluid specimens and dried blood spots on the market today.

Procurement / Program Name New Born Screening Program
Contractor Name(s) Aviog, Inc.
Contract Period One Time Purchase
Contract Number OP032970